The ultimate convenience demanded by end-user applications places tremendous challenges on the stability and compatibility of fully pre-mixed reagents. Driven by a mission of technological innovation, Hzymes has conducted systematic research and validation across core molecular enzymes, reagent systems, and manufacturing processes, offering a brand-new solution.
Fully Pre-Mixed DNA MIX
Rock-Solid Stability
Accurate and reliable results despite fluctuations in pre-mixed environments!
• 37°C High Temperature Tolerance for 28
Days
Maintains performance in high temperatures — no worries for power outages or field testing.
• Stable Storage at 4°C for 60
Days
Breaks the traditional constraint of -20°C, offering more flexibility for temporary lab storage.
• 50 Freeze-Thaw Cycles Without Activity
Loss
Repeated use doesn’t impact amplification efficiency — saves cost and reduces aliquoting hassle.
• Batch-to-Batch
Consistency
Industrial-scale production ensures stability with CV <3% in repeat experiments.
High Sensitivity
Detects even trace amounts of nucleic acids—no signal goes unnoticed!
• Ultra-Low Detection
Limit
Single-copy sensitivity—ideal for trace nucleic acid detection.
• Wide Dynamic Range
Enables accurate
quantification from 1×10⁰ to 1×10⁸ copies/μL.
Ultra-Clean (Low Residual Contamination)
No detectable common pathogens (E. coli, P. aeruginosa, S. aureus, etc.) and minimal host DNA residue—revealing the true target!
Neisseria meningitidis |
Legionella pneumophila |
Mycobacterium tuberculosis |
Klebsiella pneumoniae |
Haemophilus influenzae |
Streptococcus pneumoniae |
Toxigenic Clostridium difficile |
Adenovirus |
Escherichia coli (E. coli) |
Bordetella pertussis |
Staphylococcus aureus |
Aeromonas hydrophila |
Pseudomonas aeruginosa |
Mycoplasma pneumoniae |
Acinetobacter baumannii |
Chlamydia pneumoniae |
BNo Detection in NTC for 16 Common Pathogens
o Reduces background noise
o Improves sequencing quality and reduces data loss
o Enhances sensitivity and reduces false positives—ideal for low-abundance samples
o Ensures quantification accuracy and improves detection of low-expression genes
o Accurate clinical diagnosis—avoids misjudgments
Broad Compatibility
Compatible with diverse samples—effortless and efficient experimentation!
• Broadly universal—internally validated to match most DNA projects on the market directly.
Detection Targets |
|
Legionella pneumophila |
Pertussis |
Streptococcus pneumoniae |
Mycoplasma pneumoniae |
Adenovirus |
Escherichia coli (E. coli) |
Neisseria meningitidis |
Toxigenic Clostridium difficile |
Haemophilus influenzae |
Acinetobacter baumannii |
Chlamydia pneumoniae |
Mycobacterium tuberculosis |
Staphylococcus aureus |
Pseudomonas aeruginosa |
Human papillomavirus (HPV) |
Hepatitis B virus |
Herpes virus |
Chlamydia trachomatis |
African swine fever virus |
Porcine circovirus |
Porcine contagious pleuropneumonia |
Streptococcus suis |
White spot syndrome virus (WSSV) |
Vibrio parahaemolyticus |
Ureaplasma urealyticum |
…… |
Porcine parvovirus |
Pseudorabies virus |
Mycobacterium bovis |
Mycoplasma gallisepticum |
…… |
|
Test Data
Ultra Stability
Performance remains stable after 28 days at 37°C with bacterial multiplex primer-probe and PCR reagents.
Ultra Sensitivity
Ultra Low Host DNA Residue
E. coli genome tested on negative samples: Hzymes reagents: 0/50 positive; Competitor reagents: 3/10 positive (Blue: Positive; Red: Negative)
Ultra Broad Compatibility
Compatible with various DNA targets using Hzymes reagents.
Product Information
Hzymes Fully Pre-Mixed Series
• Fully Pre-Mixed Taq Enzyme: HMD0210
• Fully Pre-Mixed Reverse Transcriptase:
HMD3305 (Click to learn more)
Hot-start reverse transcriptase – fast, precise, and long-lasting
• Fully Pre-Mixed RNA MIX:
HMD3913
Redefining RNA detection standards: ultra-stable, efficient, and cost-effective
• Fully Pre-Mixed DNA MIX: HMD3808
• Fully Enclosed Antibody:
HMD0321
Taq polymerase full-coverage antibody—ushering in an era of efficient, convenient amplification
• Customized Fully Pre-Mixed Services Available
Join Hzymes at Medlab Asia & Asia Health 2025 – Discover High-Performance Diagnostic Enzymes & Molecular Solutions
2025-07-11Optimized Affinity-Based Strategies for High-Integrity mRNA Purification
2025-07-09Optimized Cap 2'-O-Methyltransferase Enables Efficient Cap 1 Formation for High-Quality mRNA Synthesis
2025-07-08Unlocking Efficient mRNA Capping with Hzymes' Vaccinia Virus Capping Enzyme
2025-07-07Please contact on WhatsApp
Service Hotline: +86 400-808-5320
Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China
Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.
Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.
Service Hotline: +86 400-808-5320
Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China.
Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.
Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.
Copyright © Hzymes Biotechnology Co., Ltd. All Rights Reserved Web design
Service Hotline:
+86 400-808-5320Please contact on WhatsApp
MSG